Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Ad image

Tag: Buys

Take advantage of Best Buy’s holiday sales with Doorbuster deals on everything you need

Best Buy/CNETThe season of fun and gifts is here. This means you…

MONews MONews

Timothy Springer Buys $101,967 in Cartesian Therapeutics Shares By Investing.com

In a recent move, Timothy A. Springer, a director and major shareholder…

MONews MONews

This coal-heavy rural cooperative utility buys its first solar power plant.

This story was originally published here. canary media. Tri-State Generation and Transmission…

MONews MONews

Rapport Therapeutics Director Buys $9.5 Million in Company Stock By Investing.com

James Healy, Director of Rapport Therapeutics, Inc. (NASDAQ:RAPP), recently purchased a significant…

MONews MONews